HOME / INVESTORS / BOARD OF DIRECTORS AND CEO

Nils Siegbahn 
Chairman of the board.
Member of the board since 2021 (member and chairman of the company 2000-2009).
Born 1953.
Doctor of Technology in Chemistry and Applied Biochemistry at Lund University and M.Sc in Business and Economics at Stockholm School of Economics. Experience in research, former Marketing Director at Nicoretteand, CEO of several PerstorpB companies, Atos Medical, Pernovo, Alligator Bioscience and Niconovum. Management consultant at ACH Consultant (ongoing). Member of Sparbanksstiftelsen Syd Riskkapitalstyrelse and Celltrix AB.

Shareholding: 0 shares

Leni von Bonsdorff
Member of the board since 2021.
Born 1962.
PhD and EMBA with long experience in the plasma-derived medicine field in R&D, marketing and sales as well as leadership at among others Finnish Red Cross Blood Transfusion and Sanquin. Currently Executive Director at the International Plasma and Fractionation Association. Several positions of trust within technology academies in Finland.
Shareholding: 0 shares

Torbjörn Axelsson
Member of the board since 2021.
Born 1960.
M.Sc.in Business and Economics at Lund University with more than 30 years of experience from various positions in economics and finance in several different industries, most recently as CFO at Bona AB.
Shareholding: 0 shares

Clas Runnberg
Member of the board since 2023.
Born 1952.
Market economist with extensive experience from senior executive positions in several medtech companies including Gambro and HemoCue in Sweden, Diatek Medical Technologies, Block Medical and HemoCue in the U.S., Vidacare in the U.S. and in the Netherlands. Chairman of the board at Labex of Scandinavia, member of the board at Monivent AB and an industrial advisor to Swedish private equity fund Valedo.
Shareholding: 0 shares